Saturday, November 17, 2018

Smacking Trump: Pfizer to Raise Prices on 41 Drugs

The idea that a president can successfully centrally plan drug prices or prices of any kind is absurd.

There will be workarounds if possible. Otherwise, market distortions will take place, such, as shortages or over supplies.

President Trump recently took credit for a decline in drug prices. It was a fool's braggadocio.

Pfizer Inc. plans to resume its practice of raising drug prices early next year after bowing to pressure from President Trump over the summer when the company rolled back some increases, reports The Wall Street Journal.

It said it would raise the list prices of 41 of its prescription drugs, or 10% of its portfolio, in January.

Overall,  drug companies have raised list prices on 263 drugs so far this year by an average of 7.8%,  according to Elliot Wilbur, a Raymond James & Associates analyst.



  1. Trump can do a lot. He can stop enforcement of the reimportation ban by executive order. But he won't.

    1. Or the leftist in the House could rewrite the law as well, but that won't happen either since they are bought whores.